Non-invasive diagnosis of patients with 'at-risk' NAFLD : only fibrosis counts?

Affiliations

¹ Division of Hepatology, University Hospital Würzburg, Würzburg, Germany geier_a2@medizin.uni-wuerzburg.de geier_a2@ukw.de.
² Hepato-Gastroenterology, University Hospital, Angers, France.

Comment

Andreas Geier et al. Gut. 2020 Jul.

. 2020 Jul;69(7):1164-1165.

doi: 10.1136/gutjnl-2020-320785. Epub 2020 Mar 27.

¹ Division of Hepatology, University Hospital Würzburg, Würzburg, Germany geier_a2@medizin.uni-wuerzburg.de geier_a2@ukw.de.
² Hepato-Gastroenterology, University Hospital, Angers, France.

No abstract available

Keywords: fatty liver; health economics; liver biopsy; liver imaging; staging.

Conflict of interest statement

Competing interests: None declared.

Advances in non-invasive assessment of hepatic fibrosis.
Loomba R, Adams LA. Loomba R, et al. Gut. 2020 Jul;69(7):1343-1352. doi: 10.1136/gutjnl-2018-317593. Epub 2020 Feb 17. Gut. 2020. PMID: 32066623 Free PMC article. Review.